ScreenerHero

KALA KALA BIO, Inc.

NAS · US · Healthcare · Biotechnology · kalarx.com
0.3600USD-1.10%Mkt Cap: 6.96M $P/E: —

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company dev…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap6.96M USD
Enterprise Value-189.32K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.98M USD
Revenue/Share—
Last Price0.3600 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.05
PEG—
EV/EBITDA0.01
EV/Revenue—
P/S—
P/B0.78
EPS (TTM)-10.53
EPS (Forward)-6.67
52W Range
0.34260% of range988.50
52W High988.50 USD
52W Low0.3426 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-385.65%
ROA-284.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.99M USD
CapEx (TTM)15.00K USD
FCF Margin—
FCF Yield-264.50%
Net Debt-7.23M USD
Net Debt/EBITDA0.30
Balance Sheet
Debt/Equity0.00
Current Ratio6.88
Quick Ratio4.84
Book Value/Sh0.47 USD
Cash/Share0.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 11, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.19.34M
Float19.34M
Insiders1.24%
Institutions4.07%
Short Interest
Short Ratio0.6d
Short % Float2.31%
Short % Out.2.30%
Shares Short445.42K
Short (prev mo.)255.23K
Technical
SMA 500.6573 (-45.2%)
SMA 2009.697 (-96.3%)
Beta-2.41
S&P 52W Chg16.45%
Avg Vol (30d)1.96M
Avg Vol (10d)7.30M
Technical Indicators
RSI (14)29.3
MACD-0.1047
MACD Signal-0.1058
MACD Hist.+0.0012
BB Upper0.6521 USD
BB Middle0.4923 USD
BB Lower0.3325 USD
BB Width64.92%
ATR (14)0.0764 USD
Vol Ratio (20d)0.28x